Viking Global Investors

Asset Manager

Stamford, Connecticut, US

Description

Viking Global Investors is a global investment firm managing over $48 billion in capital, focusing on long-term, fundamental, research-based investment strategies across public and private equity, as well as credit and structured capital. Founded in 1999, the firm emphasizes intellectual honesty, ESG integration, and operational excellence to generate high risk-adjusted returns for investors.

Recent Transactions involving Viking Global Investors

Deal	Target	Platform	Buyer	Industry
QIA invests in Ensoma, a genomic medicines company	Ensoma		Bill & Melinda Gates Foundation Strategic Investment Fund Arix Bioscience Solasta Ventures F-Prime Capital Takeda Ventures SymBiosis Alexandria Venture Investments Fred Hutchinson Cancer Center Qatar Investment Authority Catalio Capital Management Mirae Asset Financial Group Cormorant Asset Management Viking Global Investors	Genomic Medicines
ZTOKSPPZO AYKYD OKVHHTUA ZITQSTQMZEMYJ CTWWKG HMXVIIJ	ZNIJAI WZCYNGY	VFRIGRZYT PNKZG	LDMVIN CPDWHS QUDRAOGJW	DMEVSMG SZZZLBHUAKF

Deal

Target

Platform

Buyer

Industry

QIA invests in Ensoma, a genomic medicines company

Ensoma

Bill & Melinda Gates Foundation Strategic Investment Fund

Arix Bioscience

Solasta Ventures

F-Prime Capital

Takeda Ventures

SymBiosis

Alexandria Venture Investments

Fred Hutchinson Cancer Center

Qatar Investment Authority

Catalio Capital Management

Mirae Asset Financial Group

Cormorant Asset Management

Viking Global Investors

Genomic Medicines

ZTOKSPPZO AYKYD OKVHHTUA ZITQSTQMZEMYJ CTWWKG HMXVIIJ

ZNIJAI WZCYNGY

VFRIGRZYT PNKZG

LDMVIN CPDWHS QUDRAOGJW

DMEVSMG SZZZLBHUAKF

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →